Table 3. Blood test results and treated insulin dose during canine adipose tissue-derived mesenchymal stem cell treatment.

	Treatment	Fructosamine	Hb/A1c	Insulin dose	TG	T. chol
		(µmol/l)	(%)	(U/kg)	(mg/dl)	(mg/dl)
Case 1	Pre-treatment	516	9.8	0.63	97	289
	Post treatment #1	490	9.7	0.63	59	259
	Post treatment #2	464	10.9	0.63	48	243
	Post treatment #3	532	8.9	0.69	46	287
	Post treatment #4	515	8.9	0.69	47	319
	Post treatment #5	354	7.4	0.79	125	320
Case 2	Pre-treatment	212	4.0	0.73	129	387
	Post treatment #1	287	6.6	0.65	97	423
	Post treatment #2	324	6.5	0.63	219	423
Case 3	Pre-treatment	433	7.4	1.10	368	410
	Post treatment #1	382	7.4	1.10	284	219
	Post treatment #2	368	7.8	1.10	-	-
	Post treatment #3	420	7.4	1.10	110	258
	Post treatment #4	375	8.0	1.10	70	324
	Post treatment #5	301	7.3	1.10	131	251
Case 4	Pre-treatment	358	9.1	0.24	1,203	355
	Post treatment #1	417	9.1	0.21	54	274
	Post treatment #2	425	-	0.19	-	-
	Post treatment #3	338	9.9	0.20	-	-
	Post treatment #4	492	11.2	0.20	51	263
	Post treatment #5	448	8.7	0.22	-	-

Hb/A1c, hemoglobin A1c; TG, triglyceride; T. chol, total cholesterol.